Table 4.

Treatment of Manifestations in Individuals with NKX6-2-Related Spastic Ataxia with Hypomyelination

Manifestation/
Concern
TreatmentConsiderations/Other
Eyes Standard treatment per ophthalmology reviewCommunity vision services through early intervention or school district
Hearing Hearing aids may be helpful; per otolaryngologist.Community hearing services through early intervention or school district
Congenital
heart defect
Standard treatment per cardiologist
Respiratory
insufficiency
Standard treatment per respiratory review; consider assisted ventilation as appropriate.
  • Airway & pulmonary assessment for evidence of ↓ pulmonary function or poor secretion mgmt
  • Sleep study
Dysphagia /
Inadequate
nutrition
Nasogastric or gastrostomy tube may be required.Maintain a low threshold for clinical feeding eval &/or radiographic swallowing study if clinical signs &/or symptoms of dysphagia.
Cryptorchidism Standard treatment per urologist
Spasticity
  • PT (incl stretching) to avoid contractures & falls
  • Trial of pharmaceutical agents (e.g., baclofen or tizanidine) as recommended by rehab specialist
  • Assess for evidence of spasticity.
  • Consider need for positioning & mobility devices, disability parking placard.
Seizures Anti-seizure medicationTypically difficult to control 1
Family/
Community
  • Appropriate social work involvement to connect families w/local resources, respite, & support
  • Care coordination to manage multiple subspecialty appointments, equipment, medications, & supplies
  • Ongoing assessment for need of palliative care involvement &/or home nursing
  • Consider involvement in adaptive sports or Special Olympics.

PT = physical therapy

1.

Education of parents regarding common seizure presentations is appropriate. For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see Epilepsy Foundation Toolbox.

From: NKX6-2-Related Disorder

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.